Denali Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Denali Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $13.1M, a 97.1% increase year-over-year.
  • Denali Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $51.5M, a 249% increase year-over-year.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $51.5M, a 249% increase from 2022.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $14.8M, a 222% increase from 2021.
  • Denali Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $4.6M, a 50.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $51.5M +$36.7M +249% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $14.8M +$10.2M +222% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $4.6M -$4.65M -50.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $9.24M -$5.98M -39.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $15.2M +$5.09M +50.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $10.1M +$8.18M +418% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $1.96M +$1.17M +150% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $781K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.